OOS – Page 53 – Pharma.Tips

Preservative loss after market storage – stability investigation failure

Analyzing Preservative Loss After Market Storage: A Comprehensive Investigation Framework The stability of pharmaceutical products post-market storage is crucial for maintaining their efficacy and safety. A recent incident highlighting significant…

Discoloration on stability during shelf-life extension – CAPA and shelf-life justification gap

Addressing Stability-Induced Discoloration During Shelf-Life Extensions: A Systematic Investigation Approach In recent times, pharmaceutical manufacturers have faced increased scrutiny regarding stability issues that lead to discoloration during shelf-life extensions. This…

Label mix-up observed during distribution qualification – regulatory inspection citation

Investigating a Label Mix-Up During Distribution Qualification In the highly regulated world of pharmaceutical manufacturing, a label mix-up during distribution qualification presents a significant risk that can lead to severe…

Serialization mismatch during distribution qualification – CAPA breakdown

Understanding Serialization Mismatch During Distribution Qualification: A CAPA Breakdown The pharmaceutical industry pays particular attention to serialization for ensuring product traceability and regulatory compliance. However, instances of serialization mismatches can…

Label mix-up observed after artwork change – CAPA breakdown

Understanding Label Mix-Ups Following Artwork Changes: A CAPA Framework A label mix-up observed after an artwork change can lead to significant regulatory implications, product quality issues, and potential patient harms.…

Label mix-up observed during inspection – CAPA breakdown

Analyzing Label Mix-Ups Found During Inspections: A CAPA Breakdown During pharmaceutical manufacturing, the integrity of product labeling is critical for both compliance and safety. A label mix-up can lead to…

Carton print error after artwork change – regulatory inspection citation

Identifying and Addressing Carton Print Errors Post-Artwork Change: An Investigation Framework Manufacturing defects, particularly carton print errors following an artwork update, represent significant risks during quality assurance inspections from regulatory…

Label mix-up observed during packaging operations – regulatory inspection citation

Addressing Label Mix-Ups During Packaging Operations: An Investigation Framework Label mix-ups during packaging operations represent a serious compliance issue that can lead to significant regulatory citations and jeopardize patient safety.…

Tamper seal defect during distribution qualification – regulatory inspection citation

Investigating Tamper Seal Defects During Distribution Qualification for Regulatory Compliance Tamper seal defects may seem like minor issues, but they can have significant implications for regulatory compliance and product integrity.…

Serialization mismatch after artwork change – recall risk analysis

Analyzing Serialization Mismatches Post-Artwork Changes: A Comprehensive Investigation Framework In the rapidly evolving pharmaceutical landscape, changes in product packaging and labeling are both common and necessary. However, these changes can…

Incorrect shipper labeling during packaging operations – recall risk analysis

Addressing Incorrect Shipper Labeling During Packaging Operations: A Comprehensive Investigation Incorrect shipper labeling during packaging operations poses significant risks to pharmaceutical companies, including potential recalls and regulatory scrutiny. This article…

Tamper seal defect after artwork change – regulatory inspection citation

Investigating Tamper Seal Defects Following Artwork Changes in Pharmaceutical Packaging In the pharmaceutical manufacturing landscape, the integrity of packaging is crucial for ensuring product quality and compliance. A common yet…